About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

KISSEI PHARMACEUTICAL CO.,LTD.(4547) Summary

4547
TSE Prime
KISSEI PHARMACEUTICAL CO.,LTD.
3,795
JPY
+50
(+1.34%)
May 1, 3:30 pm JST
26.31
USD
May 1, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
13.8
PBR
0.77
Yield
2.37%
Margin Trading Ratio
1.22
Stock Price
May 1, 2025
Opening May 1, 9:00 am
3,770 JPY 26.35 USD
Previous Close Apr 30
3,745 JPY 26.27 USD
High May 1, 11:29 am
3,795 JPY 26.52 USD
Low May 1, 9:01 am
3,750 JPY 26.15 USD
Volume
61,300
Trading Value
0.23B JPY 1.61M USD
VWAP
3782.36 JPY 26.22 USD
Minimum Trading Value
379,500 JPY 2,631 USD
Market Cap
0.18T JPY 1.26B USD
Number of Trades
229
Liquidity & Number of Trades
As of May 1, 2025
Liquidity
Mid
1-Year Average
292
1-Year High Dec 25, 2024
1,180
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 7,000 25,100 3.59
Apr 18, 2025 7,200 24,700 3.43
Apr 11, 2025 7,700 26,400 3.43
Apr 4, 2025 7,700 19,400 2.52
Mar 28, 2025 7,900 40,200 5.09
Company Profile
KISSEI PHARMACEUTICAL CO.,LTD. is a mid-sized pharmaceutical company. Its main products include drugs for hyperlipidemia and urination improvement. The company focuses on dialysis, healthcare, and new drug development.
Sector
Pharmaceuticals
KISSEI PHARMACEUTICAL CO.,LTD. is a mid-sized pharmaceutical company with its pharmaceutical business accounting for over 80% of its sales. The company also operates in merchandise sales, information services, and construction contracting. In addition to manufacturing and selling its own developed prescription drugs, the company also purchases and resells medical drugs and healthcare foods. Overseas, through its subsidiaries, the company gathers and analyzes information related to pharmaceutical development and supports research and development work outsourced to foreign research institutions. The merchandise sales business develops and sells noodle products, primarily Shinshu soba, as well as equipment, vehicles, fuel, and insurance agency services. The information services business provides system integration services, information equipment rental, and network construction as part of its system resource services. The construction contracting business offers comprehensive construction services, from building to equipment and facility management.